APA
Caldwell R. D., Qiu H., Askew B. C., Bender A. T., Brugger N., Camps M., Dhanabal M., Dutt V., Eichhorn T., Gardberg A. S., Goutopoulos A., Grenningloh R., Head J., Healey B., Hodous B. L., Huck B. R., Johnson T. L., Jones C., Jones R. C., Mochalkin I., Morandi F., Nguyen N., Meyring M., Potnick J. R., Santos D. C., Schmidt R., Sherer B., Shutes A., Urbahns K., Follis A. V., Wegener A. A., Zimmerli S. C. & Liu-Bujalski L. (20200629). Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases. : Journal of medicinal chemistry.
Chicago
Caldwell Richard D, Qiu Hui, Askew Ben C, Bender Andrew T, Brugger Nadia, Camps Montserrat, Dhanabal Mohanraj, Dutt Vikram, Eichhorn Thomas, Gardberg Anna S, Goutopoulos Andreas, Grenningloh Roland, Head Jared, Healey Brian, Hodous Brian L, Huck Bayard R, Johnson Theresa L, Jones Christopher, Jones Reinaldo C, Mochalkin Igor, Morandi Federica, Nguyen Ngan, Meyring Michael, Potnick Justin R, Santos Dusica Cvetinovic, Schmidt Ralf, Sherer Brian, Shutes Adam, Urbahns Klaus, Follis Ariele Viacava, Wegener Ansgar A, Zimmerli Simone C and Liu-Bujalski Lesley. 20200629. Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases. : Journal of medicinal chemistry.
Harvard
Caldwell R. D., Qiu H., Askew B. C., Bender A. T., Brugger N., Camps M., Dhanabal M., Dutt V., Eichhorn T., Gardberg A. S., Goutopoulos A., Grenningloh R., Head J., Healey B., Hodous B. L., Huck B. R., Johnson T. L., Jones C., Jones R. C., Mochalkin I., Morandi F., Nguyen N., Meyring M., Potnick J. R., Santos D. C., Schmidt R., Sherer B., Shutes A., Urbahns K., Follis A. V., Wegener A. A., Zimmerli S. C. and Liu-Bujalski L. (20200629). Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases. : Journal of medicinal chemistry.
MLA
Caldwell Richard D, Qiu Hui, Askew Ben C, Bender Andrew T, Brugger Nadia, Camps Montserrat, Dhanabal Mohanraj, Dutt Vikram, Eichhorn Thomas, Gardberg Anna S, Goutopoulos Andreas, Grenningloh Roland, Head Jared, Healey Brian, Hodous Brian L, Huck Bayard R, Johnson Theresa L, Jones Christopher, Jones Reinaldo C, Mochalkin Igor, Morandi Federica, Nguyen Ngan, Meyring Michael, Potnick Justin R, Santos Dusica Cvetinovic, Schmidt Ralf, Sherer Brian, Shutes Adam, Urbahns Klaus, Follis Ariele Viacava, Wegener Ansgar A, Zimmerli Simone C and Liu-Bujalski Lesley. Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases. : Journal of medicinal chemistry. 20200629.